SlideShare a Scribd company logo
1 of 36
Download to read offline
1
Micro-array study for gene
expression in
atherosclerotic plaques and
its correlation with pH,
temperature, spectroscopy,
histopathology,and other
variables of vulnerability
of plaque rupture
2
History
cDNA microarrays have evolved from Southern blots, withcDNA microarrays have evolved from Southern blots, with
clone libraries gridded out on nylon membrane filtersclone libraries gridded out on nylon membrane filters
being an important and still widely used intermediate.being an important and still widely used intermediate.
Things took off with the introduction of non-porous solidThings took off with the introduction of non-porous solid
supports, such as glass - these permitted miniaturization -supports, such as glass - these permitted miniaturization -
and fluorescence based detection. Currently, about 20,000and fluorescence based detection. Currently, about 20,000
cDNAs can be spotted onto a microscope slide.cDNAs can be spotted onto a microscope slide.
3
Applications of DNA array
 Gene expression profilingGene expression profiling
 De novo gene sequencingDe novo gene sequencing
 Gene mutation analysis(SNP)Gene mutation analysis(SNP)
 Gene mapping and genotypingGene mapping and genotyping
4
What is Expression Profiling
o Technique that determines which genes areTechnique that determines which genes are
“turned on” and which genes are “turned off” in“turned on” and which genes are “turned off” in
response to developmental cues, external stimuli,response to developmental cues, external stimuli,
or a variety of stresses. Useful for comparingor a variety of stresses. Useful for comparing
differences in gene expression between normaldifferences in gene expression between normal
and diseased tissues.and diseased tissues.
o Understand general biological/biochemicalUnderstand general biological/biochemical
processesprocesses
o Identify gene targets for drug developmentIdentify gene targets for drug development
o Functional genomicsFunctional genomics
5
Gene Expression
o Pattern of expression of genes in aPattern of expression of genes in a
particular cell is a characteristic of its stateparticular cell is a characteristic of its state
o Expression patterns of many previouslyExpression patterns of many previously
uncharacterized genes may provide possibleuncharacterized genes may provide possible
clues to their functionalities by comparisonclues to their functionalities by comparison
o Can combine with metabolic schemas toCan combine with metabolic schemas to
understand how pathways are changedunderstand how pathways are changed
under varying conditionsunder varying conditions
6
Probe Design
Target
Target
Label
Bind/Wash
Image
Analyze
Typical Microarray Experiment
Oligo
cDNA
Protein
Total RNA
mRNA
cDNA
Amplication
No-amplication
Enzymatic
Chemical
Salt
Temperature
Concentration
Surface Charge
Fluorescence
Background
Light Source
7
 PROBE DESIGNPROBE DESIGN
Target
Target
Gene
Generate
20-25 mers
Fold
Blast
Select
sequences
Probe
Incorrect
Structures
Eliminated
Incorrect
Sequences
Eliminated
Incorrect
Binding
Eliminated
8
Genes involved in stable and
unstable atherosclerotic plaque
9
Il-6
IL-5
Il-4
IL-3
IL-2
Il-1Inetrleukines
HMG-COA reductase
Apo(a)
ABC
Caveolin
Apo-E
Apo-ALipid metabolism
Inhibitor of apoptosis protein-1, stannin
Caspase
C-myc
Bax
Bcl-2
CG12-1
AG8-1
Ca2-1
Fas ligand
p16
p27
P21
P53Apoptosis1
10
MMP-16
MMP-15
MMP-14
MMP -13
MMP-12
MMP-11
MMP-10
MMP-9
MMP-8
MMP-7
MMP-3
MMP-2
MMP-1Matrix metalloprotienases and their inhibitors
IL-18
IL-17
IL-16
IL-15
IL-14
IL-13
IL-12
Il-11
IL-10
IL-9
IL-8
Il-7
11Papain
Fiacin
Chymopapain
Cathepsin B
Caspases
Calpain
BromelainsCysteine Endopeptidase
Dipeptidyl PeptidaseCathepsin
BrinolaseBrinolase
Renin
Pepsin A
HIV Protease
Chymosin
Cathepsin B
CathepsinE
Cathepsin DAspartic Endopeptidase
TIMP-14
TIMP-9
TIMP-3
TIMP-2
TIMP-1
MMP-20
MMP-19
MMP-17
12
thrombin
prothrombin
Methylenetetraydrofolate reductaseThrombosis
Venombin A
Urinary plasminogen Activator
Trypsin
TPA
Thrombin
Subtilisins
Pronase
Plasminogen Activators
Plasmin
Pancreatic elastase
Kallikerins
FactorXIIa
Factor Xa
FactorVIIa
Factor IXa
Enteropeptidase
Endopeptidase K
Complement Factor I
Complement Factor D
Complement Factor B
Chymotrypsin
AcrosinSerine Endopeptidase
13E-Selectin
Angiotensin receptor
VCAM-1
ICAM-1
Cadherin
Antigens CD 31Cell Adhesion molecules
ACE
nNOS
eNOS
iNOS
bradykinin
endothelin
eNO synthaseEndothelial dysfunction(NO)
Glycoprotein IIA/IIB
Coagulation factor V
ADP
serotonin
TX
PGI2
PAI-1
PA
PAF
ICAM
thrombin
14
UCP
LDH-AOther genes
FGF-a
FGF-b
thromboplastin
IGF
PDGF
VEGF
ELC
MCP-4
MIP-beta
MIP-alpha
Rantes
CCr2(receptor)
MCP-1Chemokines
dismutase
NADP oxidaze
NAD oxidazeOxidants/Reductas,e Redox Regulators
PPAR-gamma
PPRA-alphaNuclear factors and receptors
NF-Kappa-B
Integrin-beta
Integrin-alpha
L-Selectin
P-Selectin
15
16
17
18
Folding
 The next step involves folding of the RNAThe next step involves folding of the RNA
structure, and trying to locate the primers onstructure, and trying to locate the primers on
these structurethese structure
 If the position of the primer is free ofIf the position of the primer is free of
excessive hydrogen bonding, repetition ofexcessive hydrogen bonding, repetition of
bases ,we then select it, and repeat this stepbases ,we then select it, and repeat this step
on all the possible structures of RNAon all the possible structures of RNA
19
20
 Ordering of probesOrdering of probes
 Syntesizing mRNASyntesizing mRNA
 Forming cDNAForming cDNA
21Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Preparing RNA:
RNA ISOLATION
cDNA PRODUCTION
Designing experiments to profile conditions/perturbations/
mutations and carefully controlled growth conditions
RNA yield and purity are determined by system. PolyA isolation is preferable
but total RNA is useable. Two RNA samples are hybridized/chip.
Single strand synthesis or amplification of RNA can be performed.
cDNA production includes incorporation of Aminoallyl-dUTP.
Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Preparing RNA:
RNA ISOLATION
cDNA PRODUCTION
Designing experiments to profile conditions/perturbations/
mutations and carefully controlled growth conditions
RNA yield and purity are determined by system. PolyA isolation is preferable
but total RNA is useable. Two RNA samples are hybridized/chip.
Single strand synthesis or amplification of RNA can be performed.
cDNA production includes incorporation of Aminoallyl-dUTP.
Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Preparing RNA:
RNA ISOLATION
cDNA PRODUCTION
Designing experiments to obtain conditions necessary to
induce changes in the plaque to cause its rupture
RNA yield and purity are determined by system.
Single strand synthesis or amplification of RNA can be performed.
OBTAINING THE
TARGET TISSUE
22
Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
THE PROCESSTHE PROCESS
Building the Chip:
MASSIVE PCR PCR PURIFICATION
and PREPARATION
PREPARING
SLIDES
PRINTING
Preparing RNA:
CELL CULTURE
AND HARVEST
RNA ISOLATION
cDNA PRODUCTION
Hybing the Chip:
POST PROCESSING
ARRAY HYBRIDIZATION
PROBE LABELING
DATA ANALYSIS
23Department of Statistics, University of California, Berkeley, and
Hybing the Chip:
ARRAY HYBRIDIZATION
PROBE LABELING
DATA ANALYSIS
Cy3 and Cy5 RNA samples are simultaneously
hybridized to chip. Hybs are performed for 5-12 hours
and then chips are washed.
Two RNA samples are labelled with Cy3 or
Cy5 monofunctional dyes via a chemical
coupling to AA-dUTP. Samples are purified
using a PCR cleanup kit.
Ratio measurements are determined via
quantification of 532 nm and 635 nm
emission values. Data are uploaded to the
appropriate database where statistical and
other analyses can then be performed.
24Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
cDNA clones
(probes)
PCR product amplification
purification
printing
microarray Hybridise target
to microarray
mRNA target)
excitation
laser 1laser 2
emission
scanning
analysis
overlay images and normalise
0.1nl/spot
25Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Biological
Question
Sample
preparationMicroarray
Life Cycle
Data Analysis
& Modeling
Microarray
Reaction
Microarray
Detection
aken from Schena & Davis
26
Schematic of probe preparation , hybridization,
scanning and immage analysis
27
28
Our Aim
 We intend first to create our own chip based onWe intend first to create our own chip based on
the genes that we selectedthe genes that we selected
 Then we will correlate the expression profiling ofThen we will correlate the expression profiling of
these genes with the temperature, pH,these genes with the temperature, pH,
spectroscopy,and histopathology of atheroscleroticspectroscopy,and histopathology of atherosclerotic
plaquesplaques
 We will also correlate the expression of theseWe will also correlate the expression of these
genes on the influenza infected mice, as well as ongenes on the influenza infected mice, as well as on
mice, whose plaques are prompted to rupture bymice, whose plaques are prompted to rupture by
injecting drugsinjecting drugs
29
Human Carotid artery Specimens
 We will take specimens of human carotid arteriesWe will take specimens of human carotid arteries
from endarterectomy resultsfrom endarterectomy results
 Specimens will be from both symptomatic andSpecimens will be from both symptomatic and
asymptomatic patientsasymptomatic patients
 We will study the correlation betweenWe will study the correlation between
histopathological findings with those of patient’shistopathological findings with those of patient’s
sypmtoms, and also correlate them withsypmtoms, and also correlate them with
differences in pH,temperature, spectroscopy anddifferences in pH,temperature, spectroscopy and
interpret our findings in terms of expression ofinterpret our findings in terms of expression of
genes in both groupsgenes in both groups
30
Human Coronary artery
Specimens
 We will take specimens of human coronaryWe will take specimens of human coronary
arteries from patients undergoing atherectomy orarteries from patients undergoing atherectomy or
angioplasty with distal protectionangioplasty with distal protection
 Specimens will be from both stable and unstableSpecimens will be from both stable and unstable
patientspatients
 We will study the correlation between geneWe will study the correlation between gene
expression profile, histopathological findingsexpression profile, histopathological findings
patient’s clinical presentation etc, .patient’s clinical presentation etc, .
31
Specimens from Influenza
infected apo-e mice
 We will take specimens fromWe will take specimens from
atherosclerotic plaques of influenza infectedatherosclerotic plaques of influenza infected
micemice
 After achieving this goal we will perform micro-After achieving this goal we will perform micro-
array study on these specimens and will try to findarray study on these specimens and will try to find
out which genes are expressed more in theseout which genes are expressed more in these
specimens, and we will compare our results at thespecimens, and we will compare our results at the
histopathology lab which will define the structuralhistopathology lab which will define the structural
details of such vulnerable plaques.details of such vulnerable plaques.
32
Specimens from Atherosclerotic plaque
of apo-e mice prompted to rupture
 We intend to induce rupture of atherosclerotic plaque inWe intend to induce rupture of atherosclerotic plaque in
apo-e mice by injecting several drugs, which we hope willapo-e mice by injecting several drugs, which we hope will
cause rupture of the plaque by altering the hemodynamiccause rupture of the plaque by altering the hemodynamic
system and raising the oxidative stress and alter thesystem and raising the oxidative stress and alter the
composition of the plaque.composition of the plaque.
 After achieving this goal we will perform micro- arrayAfter achieving this goal we will perform micro- array
study on these specimens and will try to find out whichstudy on these specimens and will try to find out which
genes are expressed more in plaques which are ruptured orgenes are expressed more in plaques which are ruptured or
are prone to rupture, by comparing our results at theare prone to rupture, by comparing our results at the
histopathology lab which will define the structural detailshistopathology lab which will define the structural details
of such vulnerable plaques.of such vulnerable plaques.
33Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Carotid
artery
Coronary
artery
34
• Drugs being used to
induce rupture of
atherosclerotic plaque
in apo-e mice
35
Drugs being used
• LNAME
• Adrenalin
• Cocaine
• Xanthine
• Xanthine Oxidase
• Interleukin-1 beta
• Methionine
• Buthionine Sulfoximine
36
If we do not find
anything
Very pleasant, at least
we shalll find
something new

More Related Content

What's hot

Microbiome Profiling with the Microbial Genomics Pro Suite
Microbiome Profiling with the Microbial Genomics Pro SuiteMicrobiome Profiling with the Microbial Genomics Pro Suite
Microbiome Profiling with the Microbial Genomics Pro SuiteQIAGEN
 
Making genome edits in mammalian cells
Making genome edits in mammalian cellsMaking genome edits in mammalian cells
Making genome edits in mammalian cellsChris Thorne
 
Crispr cas9-Creative Biogene
Crispr cas9-Creative BiogeneCrispr cas9-Creative Biogene
Crispr cas9-Creative BiogeneDonglin Bao
 
Automated Nucleic Acid Purification from Diverse Sample types using dedicated...
Automated Nucleic Acid Purification from Diverse Sample types using dedicated...Automated Nucleic Acid Purification from Diverse Sample types using dedicated...
Automated Nucleic Acid Purification from Diverse Sample types using dedicated...QIAGEN
 
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...QIAGEN
 
Sample Prep Solutions for Microbiome Research
Sample Prep Solutions for Microbiome ResearchSample Prep Solutions for Microbiome Research
Sample Prep Solutions for Microbiome ResearchQIAGEN
 
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Affymetrix
 
Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;applicationFyzah Bashir
 
Guide to Molecular Cloning - Download the Guide
Guide to Molecular Cloning  - Download the GuideGuide to Molecular Cloning  - Download the Guide
Guide to Molecular Cloning - Download the GuideQIAGEN
 
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...Dr. Érica Schulze
 
Analyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingAnalyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingQIAGEN
 
DNA Analysis - Basic Research : A Case Study
DNA Analysis - Basic Research : A Case StudyDNA Analysis - Basic Research : A Case Study
DNA Analysis - Basic Research : A Case StudyQIAGEN
 
Genome Editing Comes Of Age
Genome Editing Comes Of AgeGenome Editing Comes Of Age
Genome Editing Comes Of AgeChris Thorne
 
An Approach to De-convolution of Mixtures in Touch DNA Samples. Download now!
An Approach to De-convolution of Mixtures in Touch DNA Samples.   Download now!An Approach to De-convolution of Mixtures in Touch DNA Samples.   Download now!
An Approach to De-convolution of Mixtures in Touch DNA Samples. Download now!QIAGEN
 
Molecular markers in legumes
Molecular markers in legumesMolecular markers in legumes
Molecular markers in legumesAbdul GHAFOOR
 
CRISPR bacterial transformation mixes
CRISPR bacterial transformation mixesCRISPR bacterial transformation mixes
CRISPR bacterial transformation mixesJohn Kozlosky
 

What's hot (19)

Crispr/Cas9
Crispr/Cas9Crispr/Cas9
Crispr/Cas9
 
Microbiome Profiling with the Microbial Genomics Pro Suite
Microbiome Profiling with the Microbial Genomics Pro SuiteMicrobiome Profiling with the Microbial Genomics Pro Suite
Microbiome Profiling with the Microbial Genomics Pro Suite
 
Making genome edits in mammalian cells
Making genome edits in mammalian cellsMaking genome edits in mammalian cells
Making genome edits in mammalian cells
 
Crispr cas9-Creative Biogene
Crispr cas9-Creative BiogeneCrispr cas9-Creative Biogene
Crispr cas9-Creative Biogene
 
Automated Nucleic Acid Purification from Diverse Sample types using dedicated...
Automated Nucleic Acid Purification from Diverse Sample types using dedicated...Automated Nucleic Acid Purification from Diverse Sample types using dedicated...
Automated Nucleic Acid Purification from Diverse Sample types using dedicated...
 
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
 
Sample Prep Solutions for Microbiome Research
Sample Prep Solutions for Microbiome ResearchSample Prep Solutions for Microbiome Research
Sample Prep Solutions for Microbiome Research
 
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
 
Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;application
 
Guide to Molecular Cloning - Download the Guide
Guide to Molecular Cloning  - Download the GuideGuide to Molecular Cloning  - Download the Guide
Guide to Molecular Cloning - Download the Guide
 
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...
PRODUCTION OF SEROTYPE 6-DERIVED RECOMBINANT ADENO-ASSOCIATED VIRUS IN SERUM-...
 
Analyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation SequencingAnalyzing Fusion Genes Using Next-Generation Sequencing
Analyzing Fusion Genes Using Next-Generation Sequencing
 
DNA Analysis - Basic Research : A Case Study
DNA Analysis - Basic Research : A Case StudyDNA Analysis - Basic Research : A Case Study
DNA Analysis - Basic Research : A Case Study
 
Genome Editing Comes Of Age
Genome Editing Comes Of AgeGenome Editing Comes Of Age
Genome Editing Comes Of Age
 
An Approach to De-convolution of Mixtures in Touch DNA Samples. Download now!
An Approach to De-convolution of Mixtures in Touch DNA Samples.   Download now!An Approach to De-convolution of Mixtures in Touch DNA Samples.   Download now!
An Approach to De-convolution of Mixtures in Touch DNA Samples. Download now!
 
20140710 6 c_mason_ercc2.0_workshop
20140710 6 c_mason_ercc2.0_workshop20140710 6 c_mason_ercc2.0_workshop
20140710 6 c_mason_ercc2.0_workshop
 
Dna microarray mehran- u of toronto
Dna microarray  mehran- u of torontoDna microarray  mehran- u of toronto
Dna microarray mehran- u of toronto
 
Molecular markers in legumes
Molecular markers in legumesMolecular markers in legumes
Molecular markers in legumes
 
CRISPR bacterial transformation mixes
CRISPR bacterial transformation mixesCRISPR bacterial transformation mixes
CRISPR bacterial transformation mixes
 

Viewers also liked

Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stoneSHAPE Society
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for printSHAPE Society
 
249 the most cost effective therapy
249 the most cost effective therapy249 the most cost effective therapy
249 the most cost effective therapySHAPE Society
 
197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice197 reducing atherosclerosis in mice
197 reducing atherosclerosis in miceSHAPE Society
 
169 coronary artery surgery study
169 coronary artery surgery study169 coronary artery surgery study
169 coronary artery surgery studySHAPE Society
 
171 mm ps the dirty dozen
171 mm ps the dirty dozen171 mm ps the dirty dozen
171 mm ps the dirty dozenSHAPE Society
 
174 multicontrast mri
174 multicontrast mri174 multicontrast mri
174 multicontrast mriSHAPE Society
 
179 chlamydophila pneumoniae
179 chlamydophila pneumoniae179 chlamydophila pneumoniae
179 chlamydophila pneumoniaeSHAPE Society
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understandingSHAPE Society
 
187 athero reversa mice
187 athero reversa mice187 athero reversa mice
187 athero reversa miceSHAPE Society
 
510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or pparSHAPE Society
 
1 spio-mri studies by dr naghavi - amersham oct 2003
1 spio-mri studies by dr naghavi - amersham oct 20031 spio-mri studies by dr naghavi - amersham oct 2003
1 spio-mri studies by dr naghavi - amersham oct 2003SHAPE Society
 
250 patients with very abnormal test results
250 patients with very abnormal test results250 patients with very abnormal test results
250 patients with very abnormal test resultsSHAPE Society
 
183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistanceSHAPE Society
 
152 spio photographs
152 spio photographs152 spio photographs
152 spio photographsSHAPE Society
 
065 association for eradication of heart attack
065 association for eradication of heart attack065 association for eradication of heart attack
065 association for eradication of heart attackSHAPE Society
 

Viewers also liked (20)

Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
249 the most cost effective therapy
249 the most cost effective therapy249 the most cost effective therapy
249 the most cost effective therapy
 
197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice
 
169 coronary artery surgery study
169 coronary artery surgery study169 coronary artery surgery study
169 coronary artery surgery study
 
Barth imt
Barth imtBarth imt
Barth imt
 
171 mm ps the dirty dozen
171 mm ps the dirty dozen171 mm ps the dirty dozen
171 mm ps the dirty dozen
 
174 multicontrast mri
174 multicontrast mri174 multicontrast mri
174 multicontrast mri
 
179 chlamydophila pneumoniae
179 chlamydophila pneumoniae179 chlamydophila pneumoniae
179 chlamydophila pneumoniae
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 
187 athero reversa mice
187 athero reversa mice187 athero reversa mice
187 athero reversa mice
 
510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar
 
102 hot plaque
102 hot plaque102 hot plaque
102 hot plaque
 
1 spio-mri studies by dr naghavi - amersham oct 2003
1 spio-mri studies by dr naghavi - amersham oct 20031 spio-mri studies by dr naghavi - amersham oct 2003
1 spio-mri studies by dr naghavi - amersham oct 2003
 
162 calcium imaging
162 calcium imaging162 calcium imaging
162 calcium imaging
 
250 patients with very abnormal test results
250 patients with very abnormal test results250 patients with very abnormal test results
250 patients with very abnormal test results
 
183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance
 
152 spio photographs
152 spio photographs152 spio photographs
152 spio photographs
 
065 association for eradication of heart attack
065 association for eradication of heart attack065 association for eradication of heart attack
065 association for eradication of heart attack
 

Similar to 132 gene expression in atherosclerotic plaques

126 micro array study for gene expression
126 micro array study for gene expression126 micro array study for gene expression
126 micro array study for gene expressionSHAPE Society
 
Micro seminar
Micro seminarMicro seminar
Micro seminaraka_sam15
 
Molecular methods of diagnosing infectious disease
Molecular methods of diagnosing infectious diseaseMolecular methods of diagnosing infectious disease
Molecular methods of diagnosing infectious diseaseaka_sam15
 
VAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptx
VAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptxVAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptx
VAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptxVaishnaviGhugal
 
(050407)protein chip
(050407)protein chip(050407)protein chip
(050407)protein chipnamvgta
 
Applications of microarray
Applications of microarrayApplications of microarray
Applications of microarrayprateek kumar
 
6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptxArdiansyahPrayitno2
 
PCR, RT-PCR, FISH
PCR, RT-PCR, FISHPCR, RT-PCR, FISH
PCR, RT-PCR, FISHtcha163
 
Therapeutic Patterns In Genetic Analysis
Therapeutic Patterns In Genetic AnalysisTherapeutic Patterns In Genetic Analysis
Therapeutic Patterns In Genetic AnalysisJana Clark
 
Total RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarTotal RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarQIAGEN
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptxashharnomani
 
Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip KAUSHAL SAHU
 
Using methylation patterns to determine origin of biological material and age
Using methylation patterns to determine origin of biological material and ageUsing methylation patterns to determine origin of biological material and age
Using methylation patterns to determine origin of biological material and ageQIAGEN
 
DNA Markers Techniques for Plant Varietal Identification
DNA Markers Techniques for Plant Varietal Identification DNA Markers Techniques for Plant Varietal Identification
DNA Markers Techniques for Plant Varietal Identification Senthil Natesan
 

Similar to 132 gene expression in atherosclerotic plaques (20)

126 micro array study for gene expression
126 micro array study for gene expression126 micro array study for gene expression
126 micro array study for gene expression
 
Micro seminar
Micro seminarMicro seminar
Micro seminar
 
Molecular methods of diagnosing infectious disease
Molecular methods of diagnosing infectious diseaseMolecular methods of diagnosing infectious disease
Molecular methods of diagnosing infectious disease
 
VAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptx
VAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptxVAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptx
VAISHNAVI GHUGAL(SCREENING OF RECOMBINANTS).pptx
 
(050407)protein chip
(050407)protein chip(050407)protein chip
(050407)protein chip
 
Applications of microarray
Applications of microarrayApplications of microarray
Applications of microarray
 
6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx6. Molek tech.pptx [Repaired].pptx
6. Molek tech.pptx [Repaired].pptx
 
Blotting techniques ppt
Blotting techniques pptBlotting techniques ppt
Blotting techniques ppt
 
PCR, RT-PCR, FISH
PCR, RT-PCR, FISHPCR, RT-PCR, FISH
PCR, RT-PCR, FISH
 
155 dna microarray
155 dna microarray155 dna microarray
155 dna microarray
 
155 dna microarray
155 dna microarray155 dna microarray
155 dna microarray
 
Dna microarray mehran
Dna microarray  mehranDna microarray  mehran
Dna microarray mehran
 
Dna microarray application in vp research mehran
Dna microarray application in vp research  mehranDna microarray application in vp research  mehran
Dna microarray application in vp research mehran
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Therapeutic Patterns In Genetic Analysis
Therapeutic Patterns In Genetic AnalysisTherapeutic Patterns In Genetic Analysis
Therapeutic Patterns In Genetic Analysis
 
Total RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarTotal RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development Webinar
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
 
Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip
 
Using methylation patterns to determine origin of biological material and age
Using methylation patterns to determine origin of biological material and ageUsing methylation patterns to determine origin of biological material and age
Using methylation patterns to determine origin of biological material and age
 
DNA Markers Techniques for Plant Varietal Identification
DNA Markers Techniques for Plant Varietal Identification DNA Markers Techniques for Plant Varietal Identification
DNA Markers Techniques for Plant Varietal Identification
 

More from SHAPE Society

101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 fSHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)SHAPE Society
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)SHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)SHAPE Society
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for printSHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermographySHAPE Society
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st centurySHAPE Society
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosisSHAPE Society
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factorSHAPE Society
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02SHAPE Society
 

More from SHAPE Society (20)

101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
103100
103100103100
103100
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02
 
1031 talk2
1031 talk21031 talk2
1031 talk2
 
512 low t3 syndrome
512 low t3 syndrome512 low t3 syndrome
512 low t3 syndrome
 

Recently uploaded

Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedSBL DIGITAL
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxVeereshDemashetti
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfNetHelix
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdfHongBiThi1
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptxMrStavanUdayKadam
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxsiddharthroy26587
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 

Recently uploaded (20)

Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptx
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdf
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptx
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 

132 gene expression in atherosclerotic plaques

  • 1. 1 Micro-array study for gene expression in atherosclerotic plaques and its correlation with pH, temperature, spectroscopy, histopathology,and other variables of vulnerability of plaque rupture
  • 2. 2 History cDNA microarrays have evolved from Southern blots, withcDNA microarrays have evolved from Southern blots, with clone libraries gridded out on nylon membrane filtersclone libraries gridded out on nylon membrane filters being an important and still widely used intermediate.being an important and still widely used intermediate. Things took off with the introduction of non-porous solidThings took off with the introduction of non-porous solid supports, such as glass - these permitted miniaturization -supports, such as glass - these permitted miniaturization - and fluorescence based detection. Currently, about 20,000and fluorescence based detection. Currently, about 20,000 cDNAs can be spotted onto a microscope slide.cDNAs can be spotted onto a microscope slide.
  • 3. 3 Applications of DNA array  Gene expression profilingGene expression profiling  De novo gene sequencingDe novo gene sequencing  Gene mutation analysis(SNP)Gene mutation analysis(SNP)  Gene mapping and genotypingGene mapping and genotyping
  • 4. 4 What is Expression Profiling o Technique that determines which genes areTechnique that determines which genes are “turned on” and which genes are “turned off” in“turned on” and which genes are “turned off” in response to developmental cues, external stimuli,response to developmental cues, external stimuli, or a variety of stresses. Useful for comparingor a variety of stresses. Useful for comparing differences in gene expression between normaldifferences in gene expression between normal and diseased tissues.and diseased tissues. o Understand general biological/biochemicalUnderstand general biological/biochemical processesprocesses o Identify gene targets for drug developmentIdentify gene targets for drug development o Functional genomicsFunctional genomics
  • 5. 5 Gene Expression o Pattern of expression of genes in aPattern of expression of genes in a particular cell is a characteristic of its stateparticular cell is a characteristic of its state o Expression patterns of many previouslyExpression patterns of many previously uncharacterized genes may provide possibleuncharacterized genes may provide possible clues to their functionalities by comparisonclues to their functionalities by comparison o Can combine with metabolic schemas toCan combine with metabolic schemas to understand how pathways are changedunderstand how pathways are changed under varying conditionsunder varying conditions
  • 6. 6 Probe Design Target Target Label Bind/Wash Image Analyze Typical Microarray Experiment Oligo cDNA Protein Total RNA mRNA cDNA Amplication No-amplication Enzymatic Chemical Salt Temperature Concentration Surface Charge Fluorescence Background Light Source
  • 7. 7  PROBE DESIGNPROBE DESIGN Target Target Gene Generate 20-25 mers Fold Blast Select sequences Probe Incorrect Structures Eliminated Incorrect Sequences Eliminated Incorrect Binding Eliminated
  • 8. 8 Genes involved in stable and unstable atherosclerotic plaque
  • 9. 9 Il-6 IL-5 Il-4 IL-3 IL-2 Il-1Inetrleukines HMG-COA reductase Apo(a) ABC Caveolin Apo-E Apo-ALipid metabolism Inhibitor of apoptosis protein-1, stannin Caspase C-myc Bax Bcl-2 CG12-1 AG8-1 Ca2-1 Fas ligand p16 p27 P21 P53Apoptosis1
  • 10. 10 MMP-16 MMP-15 MMP-14 MMP -13 MMP-12 MMP-11 MMP-10 MMP-9 MMP-8 MMP-7 MMP-3 MMP-2 MMP-1Matrix metalloprotienases and their inhibitors IL-18 IL-17 IL-16 IL-15 IL-14 IL-13 IL-12 Il-11 IL-10 IL-9 IL-8 Il-7
  • 11. 11Papain Fiacin Chymopapain Cathepsin B Caspases Calpain BromelainsCysteine Endopeptidase Dipeptidyl PeptidaseCathepsin BrinolaseBrinolase Renin Pepsin A HIV Protease Chymosin Cathepsin B CathepsinE Cathepsin DAspartic Endopeptidase TIMP-14 TIMP-9 TIMP-3 TIMP-2 TIMP-1 MMP-20 MMP-19 MMP-17
  • 12. 12 thrombin prothrombin Methylenetetraydrofolate reductaseThrombosis Venombin A Urinary plasminogen Activator Trypsin TPA Thrombin Subtilisins Pronase Plasminogen Activators Plasmin Pancreatic elastase Kallikerins FactorXIIa Factor Xa FactorVIIa Factor IXa Enteropeptidase Endopeptidase K Complement Factor I Complement Factor D Complement Factor B Chymotrypsin AcrosinSerine Endopeptidase
  • 13. 13E-Selectin Angiotensin receptor VCAM-1 ICAM-1 Cadherin Antigens CD 31Cell Adhesion molecules ACE nNOS eNOS iNOS bradykinin endothelin eNO synthaseEndothelial dysfunction(NO) Glycoprotein IIA/IIB Coagulation factor V ADP serotonin TX PGI2 PAI-1 PA PAF ICAM thrombin
  • 14. 14 UCP LDH-AOther genes FGF-a FGF-b thromboplastin IGF PDGF VEGF ELC MCP-4 MIP-beta MIP-alpha Rantes CCr2(receptor) MCP-1Chemokines dismutase NADP oxidaze NAD oxidazeOxidants/Reductas,e Redox Regulators PPAR-gamma PPRA-alphaNuclear factors and receptors NF-Kappa-B Integrin-beta Integrin-alpha L-Selectin P-Selectin
  • 15. 15
  • 16. 16
  • 17. 17
  • 18. 18 Folding  The next step involves folding of the RNAThe next step involves folding of the RNA structure, and trying to locate the primers onstructure, and trying to locate the primers on these structurethese structure  If the position of the primer is free ofIf the position of the primer is free of excessive hydrogen bonding, repetition ofexcessive hydrogen bonding, repetition of bases ,we then select it, and repeat this stepbases ,we then select it, and repeat this step on all the possible structures of RNAon all the possible structures of RNA
  • 19. 19
  • 20. 20  Ordering of probesOrdering of probes  Syntesizing mRNASyntesizing mRNA  Forming cDNAForming cDNA
  • 21. 21Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Preparing RNA: RNA ISOLATION cDNA PRODUCTION Designing experiments to profile conditions/perturbations/ mutations and carefully controlled growth conditions RNA yield and purity are determined by system. PolyA isolation is preferable but total RNA is useable. Two RNA samples are hybridized/chip. Single strand synthesis or amplification of RNA can be performed. cDNA production includes incorporation of Aminoallyl-dUTP. Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Preparing RNA: RNA ISOLATION cDNA PRODUCTION Designing experiments to profile conditions/perturbations/ mutations and carefully controlled growth conditions RNA yield and purity are determined by system. PolyA isolation is preferable but total RNA is useable. Two RNA samples are hybridized/chip. Single strand synthesis or amplification of RNA can be performed. cDNA production includes incorporation of Aminoallyl-dUTP. Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Preparing RNA: RNA ISOLATION cDNA PRODUCTION Designing experiments to obtain conditions necessary to induce changes in the plaque to cause its rupture RNA yield and purity are determined by system. Single strand synthesis or amplification of RNA can be performed. OBTAINING THE TARGET TISSUE
  • 22. 22 Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, THE PROCESSTHE PROCESS Building the Chip: MASSIVE PCR PCR PURIFICATION and PREPARATION PREPARING SLIDES PRINTING Preparing RNA: CELL CULTURE AND HARVEST RNA ISOLATION cDNA PRODUCTION Hybing the Chip: POST PROCESSING ARRAY HYBRIDIZATION PROBE LABELING DATA ANALYSIS
  • 23. 23Department of Statistics, University of California, Berkeley, and Hybing the Chip: ARRAY HYBRIDIZATION PROBE LABELING DATA ANALYSIS Cy3 and Cy5 RNA samples are simultaneously hybridized to chip. Hybs are performed for 5-12 hours and then chips are washed. Two RNA samples are labelled with Cy3 or Cy5 monofunctional dyes via a chemical coupling to AA-dUTP. Samples are purified using a PCR cleanup kit. Ratio measurements are determined via quantification of 532 nm and 635 nm emission values. Data are uploaded to the appropriate database where statistical and other analyses can then be performed.
  • 24. 24Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, cDNA clones (probes) PCR product amplification purification printing microarray Hybridise target to microarray mRNA target) excitation laser 1laser 2 emission scanning analysis overlay images and normalise 0.1nl/spot
  • 25. 25Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Biological Question Sample preparationMicroarray Life Cycle Data Analysis & Modeling Microarray Reaction Microarray Detection aken from Schena & Davis
  • 26. 26 Schematic of probe preparation , hybridization, scanning and immage analysis
  • 27. 27
  • 28. 28 Our Aim  We intend first to create our own chip based onWe intend first to create our own chip based on the genes that we selectedthe genes that we selected  Then we will correlate the expression profiling ofThen we will correlate the expression profiling of these genes with the temperature, pH,these genes with the temperature, pH, spectroscopy,and histopathology of atheroscleroticspectroscopy,and histopathology of atherosclerotic plaquesplaques  We will also correlate the expression of theseWe will also correlate the expression of these genes on the influenza infected mice, as well as ongenes on the influenza infected mice, as well as on mice, whose plaques are prompted to rupture bymice, whose plaques are prompted to rupture by injecting drugsinjecting drugs
  • 29. 29 Human Carotid artery Specimens  We will take specimens of human carotid arteriesWe will take specimens of human carotid arteries from endarterectomy resultsfrom endarterectomy results  Specimens will be from both symptomatic andSpecimens will be from both symptomatic and asymptomatic patientsasymptomatic patients  We will study the correlation betweenWe will study the correlation between histopathological findings with those of patient’shistopathological findings with those of patient’s sypmtoms, and also correlate them withsypmtoms, and also correlate them with differences in pH,temperature, spectroscopy anddifferences in pH,temperature, spectroscopy and interpret our findings in terms of expression ofinterpret our findings in terms of expression of genes in both groupsgenes in both groups
  • 30. 30 Human Coronary artery Specimens  We will take specimens of human coronaryWe will take specimens of human coronary arteries from patients undergoing atherectomy orarteries from patients undergoing atherectomy or angioplasty with distal protectionangioplasty with distal protection  Specimens will be from both stable and unstableSpecimens will be from both stable and unstable patientspatients  We will study the correlation between geneWe will study the correlation between gene expression profile, histopathological findingsexpression profile, histopathological findings patient’s clinical presentation etc, .patient’s clinical presentation etc, .
  • 31. 31 Specimens from Influenza infected apo-e mice  We will take specimens fromWe will take specimens from atherosclerotic plaques of influenza infectedatherosclerotic plaques of influenza infected micemice  After achieving this goal we will perform micro-After achieving this goal we will perform micro- array study on these specimens and will try to findarray study on these specimens and will try to find out which genes are expressed more in theseout which genes are expressed more in these specimens, and we will compare our results at thespecimens, and we will compare our results at the histopathology lab which will define the structuralhistopathology lab which will define the structural details of such vulnerable plaques.details of such vulnerable plaques.
  • 32. 32 Specimens from Atherosclerotic plaque of apo-e mice prompted to rupture  We intend to induce rupture of atherosclerotic plaque inWe intend to induce rupture of atherosclerotic plaque in apo-e mice by injecting several drugs, which we hope willapo-e mice by injecting several drugs, which we hope will cause rupture of the plaque by altering the hemodynamiccause rupture of the plaque by altering the hemodynamic system and raising the oxidative stress and alter thesystem and raising the oxidative stress and alter the composition of the plaque.composition of the plaque.  After achieving this goal we will perform micro- arrayAfter achieving this goal we will perform micro- array study on these specimens and will try to find out whichstudy on these specimens and will try to find out which genes are expressed more in plaques which are ruptured orgenes are expressed more in plaques which are ruptured or are prone to rupture, by comparing our results at theare prone to rupture, by comparing our results at the histopathology lab which will define the structural detailshistopathology lab which will define the structural details of such vulnerable plaques.of such vulnerable plaques.
  • 33. 33Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Carotid artery Coronary artery
  • 34. 34 • Drugs being used to induce rupture of atherosclerotic plaque in apo-e mice
  • 35. 35 Drugs being used • LNAME • Adrenalin • Cocaine • Xanthine • Xanthine Oxidase • Interleukin-1 beta • Methionine • Buthionine Sulfoximine
  • 36. 36 If we do not find anything Very pleasant, at least we shalll find something new